Share
1,997 Posts.
lightbulb Created with Sketch. 285
clock Created with Sketch. 09/09/24
10:03
Share
Originally posted by kpt3891:
↑
A better managed, less lazy and more strategic path over the last 20 years and the outcome could have been different. The company is now on it's knees financially and the only promising drug from a commercial perspective BIT225 raises more questions than answers... this after multiple Phase 2 trials over last decade. Big Pharma will not enter into a deal with significant questions remaining and much uncertainty... hence even more trials or next generation development.
Expand
interesting question. Drug / management, or both...
